- Home
- SVRE vs BDRX Comparison
SVRE vs BDRX Comparison
Compare SVRE & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- BDRX
- Stock Information
- Founded
- SVRE 2014
- BDRX 2000
- Country
- SVRE Israel
- BDRX United Kingdom
- Employees
- SVRE N/A
- BDRX N/A
- Industry
- SVRE
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- SVRE
- BDRX Health Care
- Exchange
- SVRE Nasdaq
- BDRX Nasdaq
- Market Cap
- SVRE 883.2K
- BDRX 5.8M
- IPO Year
- SVRE 2022
- BDRX N/A
- Fundamental
- Price
- SVRE $2.03
- BDRX $0.86
- Analyst Decision
- SVRE
- BDRX
- Analyst Count
- SVRE 0
- BDRX 0
- Target Price
- SVRE N/A
- BDRX N/A
- AVG Volume (30 Days)
- SVRE 3.3M
- BDRX 3.1M
- Earning Date
- SVRE 08-26-2025
- BDRX 04-11-2025
- Dividend Yield
- SVRE N/A
- BDRX N/A
- EPS Growth
- SVRE N/A
- BDRX N/A
- EPS
- SVRE N/A
- BDRX N/A
- Revenue
- SVRE $462,071.00
- BDRX N/A
- Revenue This Year
- SVRE $458.76
- BDRX N/A
- Revenue Next Year
- SVRE $106.57
- BDRX N/A
- P/E Ratio
- SVRE N/A
- BDRX N/A
- Revenue Growth
- SVRE N/A
- BDRX N/A
- 52 Week Low
- SVRE $1.93
- BDRX $0.78
- 52 Week High
- SVRE $325.36
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- SVRE 34.60
- BDRX 36.41
- Support Level
- SVRE $1.93
- BDRX $0.83
- Resistance Level
- SVRE $5.69
- BDRX $0.90
- Average True Range (ATR)
- SVRE 0.57
- BDRX 0.11
- MACD
- SVRE 0.07
- BDRX 0.00
- Stochastic Oscillator
- SVRE 2.66
- BDRX 14.57
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road and pedestrians. Geographially, it operates in Israel and Europe, out of which it derives maximum revenue from Israel.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.